← Leaderboards
Laurent Debarbieux
Georgia Institute Of Technology
$1,214,069
Attributed
$2,428,138
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $501.7K · FY2019–23$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,428,138 · 1
By mechanism
R01$2,428,138 · 1
Top collaborators
- Joshua Weitz6 shared
Most similar at Georgia Institute Of Technology
Same institution · by research overlap
- Lena H Ting$12,944,955
- Joshua Weitz$1,430,655
- Isaac Estrada$49,538
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteAcute PneumoniaAcute Respiratory InfectionAcute InfectionAntibioticsBacteriaBacterial InfectionsBacterial ResistanceBacteriophagesAnimalsBiological ModelsCellsClinical TranslationClinical TrialsCommensal BacteriaComputer SimulationControl TheoryCritical IllnessCurative TreatmentsCytolysisData IntegrationDensityDesignDosage
Grant awards (6)
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune response$294,195
R01 · FY2023 · AI
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune response$187,642
R01 · FY2023 · AI
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune response$488,107
R01 · FY2022 · AI
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune response$481,048
R01 · FY2021 · AI
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune response$475,483
R01 · FY2020 · AI
Synergistic control of acute respiratory pathogens by bacteriophage and the innate immune response$501,663
R01 · FY2019 · AI